pocketful logo light
pocketful logo light
Caplin Point Laboratories Ltd logo

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT BSE: 524742

₹2754.90

(1.45%)

Sun, 20 Sept 2026, 05:57 pm

Caplin Point Laboratories Share Price Live Chart

1 Day

(1.45%)

No Result Found

Summary

  • Market Cap (in Cr)

    15431.13

  • Net Profit (in Cr)

    541.09

  • P/B

    5.78

  • Sector P/E

    33.76

  • P/E

    28.38

  • EV/EBITDA

    19.69

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    22.86

  • ROCE

    26.03

  • Debt/Equity

    0

  • EPS (TTM)

    84.36

  • Dividend Yield

    0.20

  • Book Value

    471.83

  • Interest Cover

    1110.48

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters70.5770.5770.5770.5670.56
FII6.156.566.486.145.70
DII2.142.052.102.222.01
Public21.1420.8220.8521.0821.73
Government00000

Read More

Technical Analysis

RSI

56.98

MACD

32.40

50 DMA

2602.43

200 DMA

2077.95

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic3103.202813.602665.5025242375.902234.401944.80
Fibonacci2813.602702.972634.6325242413.372345.032234.40
Camarilla2597.042570.492543.9525242490.852464.312437.76

Pivots Level: Classic

R3

+579.20

3103.20

R2

+289.60

2813.60

R1

+141.50

2665.50

2524
2524
Pivot Point
LTP: 2748.60

S1

-148.10

2375.90

S2

-289.60

2234.40

S3

-579.20

1944.80

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    2680.11

  • 20-EMA

    2660.17

  • 30-EMA

    2635.14

  • 50-EMA

    2575.23

  • 100-EMA

    2415.10

  • 200-EMA

    2233.36

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
14 May 2026dividend₹4.00 Dividend /Share30 May 2026
14 May 2026board-meetingsAccounts, Interim Dividend
05 Feb 2026board-meetingsQuarterly Results
05 Nov 2025board-meetingsQuarterly Results
12 Aug 2025dividendFinal Dividend - Rs. - 312 Sept 2025
07 Aug 2025agm
07 Aug 2025dividend₹3.00 Dividend /Share12 Sept 2025
15 May 2025dividend₹3.00 Dividend /Share30 May 2025
30 Apr 2025dividendInterim Dividend - Rs. - 330 May 2025
23 Aug 2024dividendDividend - Rs 2.50 Per Share23 Sept 2024

Read More

Peer Comparison

Caplin Point Laboratories Ltd logo

Caplin Point Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Caplin Point Laboratories Ltd About

Caplin Point Laboratories manufactures wide range of ointments, creams and other external application preparations in addition to the regular segments of pharmaceutical formulations.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1990

Headquarters

CEO

C C Paarthipan

Employees

Contact

Website icon

Website

http://www.caplinpoint.net

Email icon

Email

investor@caplinpoint.net; info@caplinpoint.net

Phone icon

Phone

91-44-24968000/71148000/28156653

Location icon

Location

Ashvich Towers 3rd Floor, No 3 Developed Plots Ind Estat, Chennai, Tamil Nadu, 600096

Read More

Caplin Point Laboratories Ltd Company History

YearHistory
2018
  • USFDA completed inspection at Caplin Point Lab's sterile injectable facility in Tamil Nadu
2019
  • Caplin Point Laboratories partnered with Baxter Corporation for injectable portfolio
  • USFDA completed inspection at Caplin Steriles Injectable site
  • Caplin Steriles received USFDA nod for hemorrhage prevention drug
  • Caplin Point Labs received an EIR from USFDA for injectable facility
2020
  • Caplin Point Laboratories partnered with Xellia for injectable products
  • Caplin Point Laboratories received final approval from the US drug regulator for its Abbreviated New Drug Application for Phenylephrine Hydrochloride injection
  • Caplin Steriles received USFDA approval for Verapamil Hydrochloride Injection USP
2021
  • Caplin Point arm inked a strategic partnership with Canada's JAMP Pharma Group
  • Caplin Point Laboratories arm received USFDA nod for Neostigmine Methylsulfate Injection
2023
  • Caplin Point Laboratories received the Lifetime Achievement Award 2023
  • Caplin Point Laboratories received the Forbes Asia Best Under Billion Award 2023

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GRAVITON RESEARCH CAPITAL LLPbulkBuy3963551899.626 Aug 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell3963551901.2826 Aug 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell4444781763.5819 Aug 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy4444781761.7219 Aug 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy381306908.1909 Sept 2021
GRAVITON RESEARCH CAPITAL LLPbulkSell381306908.5409 Sept 2021
GRAVITON RESEARCH CAPITAL LLPbulkBuy414981957.6227 Jul 2021
GRAVITON RESEARCH CAPITAL LLPbulkSell414981957.3727 Jul 2021
XTX MARKETS LLPbulkSell460816910.5826 Jul 2021
XTX MARKETS LLPbulkBuy464203908.9126 Jul 2021

Read More

Caplin Point Laboratories Ltd News

Caplin Point Labs to host Q1 FY27 earnings call on Aug 12

Caplin Point Laboratories Limited will hold a conference call on August 12, 2026, at 4:30 PM IST to discuss its financial performance for the quarter ended June 30, 2026. The event is compliant with SEBI Regulation 30.

30 Jul 2026

companies

Caplin Point declares no encumbrance on shares in FY26

Caplin Point Laboratories Ltd disclosed that no encumbrance was created on its shares during FY26. The declaration was submitted by promoters under SEBI regulations.

16 Jun 2026

companies

Caplin Point to meet investors

Caplin Point Laboratories will attend the TRINITY INDIA 2026 conference on May 28, 2026, in Mumbai. The company will engage with analysts and institutional investors.

22 May 2026

companies

Caplin Point Q4 FY26 Earnings Call Audio Now Available

Caplin Point Laboratories confirms the audio recording of its Q4/FY2026 earnings call, held on May 14, 2026, is now available on the company's website.

15 May 2026

companies

Caplin Point Labs Eyes Canada, Australia & MENA Expansion

Caplin Point Laboratories aims to expand into new regulated markets including Canada, Australia, MENA, Russia/CIS, and larger LATAM markets such as Mexico and Brazil.

14 May 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Caplin Point Laboratories Ltd?

    As of 20/09/2026 at 11:27 PM, Caplin Point Laboratories Ltd shares are trading at ₹2754.90.

  • 2.What is the market cap. of Caplin Point Laboratories Ltd?

    As of 20/09/2026, the market capitalization of Caplin Point Laboratories Ltd is ₹20,939.32 crore.

  • 3.When was Caplin Point Laboratories Ltd founded?

    Caplin Point Laboratories Ltd was founded in 1990.

  • 4.What are the P/E and P/B ratios of Caplin Point Laboratories Ltd?

    As of 20/09/2026, Caplin Point Laboratories Ltd has a P/E ratio of 31.56 and a P/B ratio of 5.78.

  • 5.How can I buy shares of Caplin Point Laboratories Ltd?

    You can buy shares of Caplin Point Laboratories Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Caplin Point Laboratories Ltd?

    As of March,2026, promoters hold 70.57% in Caplin Point Laboratories Ltd, while FIIs, DIIs and public shareholders hold 6.15%, 2.14% and 21.14%, respectively.

  • 7.Does Caplin Point Laboratories Ltd pay dividends?

    Yes, Caplin Point Laboratories Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹4.00 Dividend /Share per share.

  • 8.What is the dividend yield of Caplin Point Laboratories Ltd?

    As of 20 September, 2026, the dividend yield of Caplin Point Laboratories Ltd stands at 0.25%.

  • 9.What are the latest financial results of Caplin Point Laboratories Ltd?

    For January,2024, Caplin Point Laboratories Ltd reported revenue of ₹1,921.00 crore and a net profit of ₹536.00 crore.

  • 10.What is the Stock symbol of Caplin Point Laboratories Ltd?

    CAPLIPOINT is the stock symbol of Caplin Point Laboratories Ltd.

  • 11.Who is the CEO of Caplin Point Laboratories Ltd?

    The CEO of Caplin Point Laboratories Ltd is C C Paarthipan.

Open Your Free Demat Account

Enter your phone number